Virdings allé 18
Uppsala 754 50
Sweden
46 8 56 26 74 30
https://www.bio-works.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 35
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jonathan Royce | Chief Executive Officer | N/A | N/A | N/A |
Mr. Jan Berglöf | Co-Founder & Senior Advisor | N/A | N/A | N/A |
Mr. Arne Hauge | Chief Financial Officer | N/A | N/A | N/A |
Mr. Karsten Fjärstedt | Chief Operating Officer | N/A | N/A | N/A |
Ms. Sara Ekvall | Director of People & Culture | N/A | N/A | N/A |
Ms. Helena Pahlm | Senior Director of Global Quality | N/A | N/A | N/A |
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
Bio-Works Technologies AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.